For the Inventor, By the Inventor

Enter assignee name

Chiome Bioscience Inc.

USPTO Granted Patents = 10

% Expired Patents = 30.0

CIPO Patents = 1

EPO Patents = 11

Trademarks = 1

Forward Citations = 4

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Koji Nakamura (3 out of 71 patents)

Yosuke Kamimura (3 out of 3 patents)

Hidetaka Seo (3 out of 7 patents)

4. Kentaro Okamura (3 out of 9 patents)

5. Maki Tamura (3 out of 4 patents)

6. Hiroyuki Yanai (3 out of 5 patents)

7. Toru Kanke (3 out of 5 patents)

8. Shankar Kumar (2 out of 31 patents)

9. Naoya Tsurushita (2 out of 50 patents)

10. Kunihiro Ohta (2 out of 11 patents)

11. Takehiko Shibata (2 out of 13 patents)

12. Keisuke Niikura (2 out of 2 patents)

13. Kotaro Yamamoto (1 out of 7 patents)

14. Nico Mertens (1 out of 2 patents)

15. Philip Jeffrey Cunnah (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12680195 - METHOD FOR PROMOTING DIVERSIFICATION OF ANTIBODY VARIABLE REGION (2026-07-14),

2. 11572402 - Method for promoting diversification of antibody variable region (2023-02-07),

3. 11008566 - Method for obtaining antibody (2021-05-18),

4. 10941207 - Fusion protein comprising three binding domains to 5T4 and CD3 (2021-03-09),

5. 10202461 - Anti-human TROP-2 antibody having an antitumor activity in vivo (2019-02-12),

6. 9670287 - Anti-human TROP-2 antibody having anti-tumor activity in vivo (2017-06-06),

7. 9587251 - Method of inducing homologous recombination of somatic cell (2017-03-07),

8. 9427464 - Anti-human TROP-2 antibody having an antitumor activity in vivo (2016-08-30),

9. 9090672 - Method for producing antibody directed against protein expressed on cell surface (2015-07-28),

10. 8187884 - Method of enhancing homologous recombination of somatic cells and method of constructing specific antibody (2012-05-29),

Chiome Bioscience Inc. is a biotechnology company based in Tokyo, Japan, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced technologies in drug discovery and development, particularly in the fields of antibody engineering and protein therapeutics. Chiome aims to address unmet medical needs through its proprietary platforms, contributing to the advancement of healthcare and improving patient outcomes globally.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#1,914 in Tokyo

#4,400 in Japan

#55,986 in the World

Chiome Bioscience Inc.

Forward Citations = 4

27 inventors:

Koji Nakamura (3 out of 71 patents)

Yosuke Kamimura (3 out of 3 patents)

Hidetaka Seo (3 out of 7 patents)

4. Kentaro Okamura (3 out of 9 patents)

5. Maki Tamura (3 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…